You are here: Home / Events / RCMI Events / The Paths to Approvals of Therapeutics and Diagnostics at the FDA in the Era of Personalized Medicine and the 21st Century Cures Legislation

The Paths to Approvals of Therapeutics and Diagnostics at the FDA in the Era of Personalized Medicine and the 21st Century Cures Legislation

When Jan 31, 2017
from 12:00 PM to 01:00 PM
Where 6th floor Amphitheater, UPR-MSC Main Building, UPR-Medical Sciences Campus
Add event to calendar vCal
iCal

by

Federico Goodsaid, Ph.D.

Vice President of Assay Development and Regulatory Affairs
TOMA Biosciences, Foster City, CA

This seminar series is supported by an NIGMS INBRE grant P20 GM103475 in collaboration with UPR-SOM Biomedical Sciences Graduate Program, Puerto Rico Clinical and Translational Research Consortium TRCL (U54 MD007587) and RCMI CGHDRD (G12 MD007600).

Navigation
National Minority Health Month

2017 Activities

ZIKA INITIATIVE

« May 2017 »
May
SuMoTuWeThFrSa
123456
78910111213
14151617181920
21222324252627
28293031
WebNews

Web News Sept 2011

Our Monthly RCMI WebNews
RTRN

Contact us!
Emma Fernández-Repollet,Ph.D.
Principal Investigator
RCMI Program
Room 621-A, 6th floor
Guillermo Arbona Building
Medical Sciences Campus
GPO Box 365067
San Juan, PR 00936-5067
Voice (787) 763-9401
FAX (787) 758-5206